PBYI
Companies
NASDAQ
Puma Biotechnology Inc.
Health Care
$3.40
+$0.35 (+11.48%)
Price Chart
Overview
About PBYI
we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Market Cap
$170.0M
Volume
1.1M
Avg. Volume
1.6M
P/E Ratio
12.041667
Dividend Yield
0.00%
Employees
238.0
Company Information
Latest News for PBYI
Risk & Correlation Analysis
Market Correlation
1.55
High Correlation
Volatility
High (0.74)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PBYI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$170.0M
Volume1.1M
P/E Ratio12.04
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025